Keyphrases
Critically Ill Patients
100%
Acute Kidney Injury
100%
Thromboprophylaxis
100%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
87%
Enoxaparin
62%
Venous Thromboembolism
25%
Major Bleeding
25%
Continuous Renal Replacement Therapy
25%
Bleeding Risk
12%
Predictive Value
12%
Medicos
12%
Once-daily
12%
Randomized Trial
12%
Accruals
12%
Dialysis
12%
EudraCT
12%
Urine Output
12%
Surgical Intensive Care Unit
12%
Regression Analysis
12%
Free Interval
12%
Resource Utilization
12%
Denmark
12%
Medicine and Dentistry
Thromboprophylaxis
100%
Acute Kidney Injury
100%
Neutrophil Gelatinase Associated Lipocalin
100%
Continuous Renal Replacement Therapy
28%
Venous Thromboembolism
28%
Major Bleeding
28%
Intensive Care Unit
14%
Clinical Trial
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
100%
Neutrophil Gelatinase Associated Lipocalin
100%
Enoxaparin
71%
Replacement Therapy
28%
Venous Thromboembolism
28%
Bleeding
28%
Clinical Trial
14%